Deal Spotlight
July 28, 2026
Juno Diagnostics raises €3.5M Seed with Perceptive Advisors leading
€3.5M
round size
series-a
stage
The funding round closed on July 1, 2026, with Perceptive Advisors leading and Ada Ventures, Artesian, Entrepreneur First, and Illumina Accelerator participating. The company has raised a total of €23M to date.
Juno Diagnostics is a genetic health information platform based in the United States operating in Healthcare & Life Sciences at the series-a stage.
Related insights
- Cross-Country AnalysisFinance & Blockchain seed funding share declines 5.9pp, matched by Industry & Hardware’s 5.9pp gain from 2021 to 2024
- Cross-Country AnalysisUS startups reach Series B 12% faster than Israeli peers after Series A
- Country AnalysisCzechia's Venture Market Punches Above Its Economic Weight
- Stage AnalysisSeries A median round size in Switzerland rose 40% from 2024 to 2025
Explore the full dataset
Brouky tracks 36,000+ investors and 100,000+ investments across 84,000+startups. Search by country, stage, and sector.